Neosartorya fischeri: An invasive fungal pathogen in an allogeneic bone marrow transplant patient

Bone Marrow Transplantation

Volumn 19, Issue 7, 1997, Pages 753-755

  Lonial, S ^a   Williams, L ^a   Carrum, G ^a   Ostrowski, M ^a   McCarthy Jr , P ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Bone marrow transplantation; Infection; Neosartorya fischeri

Indexed keywords

AMPHOTERICIN B;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CLINICAL FEATURE; FATALITY; HUMAN; MALE; MYCOSIS; PRIORITY JOURNAL;

EID: 0030994773     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700715     Document Type: Article

References (14)

1. Girardin H, Monod M, Latage JP. Molecular characterization of the food-borne fungus Neosartorya fischeri (Malloch and Cain). Appl Envir Microbiol 1995; 61: 1378-1383.
2. Samson RA, Nielsen PV, Frisvad JC. The genus Neosartorya: differentiation by scanning electron microscopy and mycotoxin profiles. In: Samson RA. Pitt JI (eds). Modern Concepts in Penicillium and Aspergillus Classification. Plenum Press: NY, 1990, pp 455-467.
3. Summerbell RC, de Repentigny L, Chartrand C, St Germain G. Graft-related endocarditis caused by Neosartorya fischeri var spinosa. J Clin Microbiol 1992; 30: 1580-1582.
4. Gerber J, Chomicki J, Brandsberg JW et al. Pulmonary aspergillosis caused by Aspergillus fischeri var spinosa. Am J Clin Palhol 1973; 60: 861-866.
5. Coriglione G, Stella G, Gafa L et al. Neosartorya fischeri var fischeri (Wehmer) Malloch and Cain 1972 (anamorph Aspergillus fischerianus Samson and Gams 1985) as a cause of mycotic keratitis. Eur J Epidemiol 1990; 6: 382-385.
6. Padhye AA, Godfrey JH, Chandler FW, Peterson SW. Osteomyelitis caused by Neosartorya pseudofischeri. J Clin Microb 1994; 32: 2832-2836.
7. Bodey G, Vartivarian S. Aspergillosis. Eur J Clin Microb Infect Dis 1989; 8: 413-437.
8. Uzun O, Anaissie E. Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal. Blood 1995; 86: 2063-2072.
9. Goodman JL, Winston DJ, Greenfield RA et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New Engl J Med 1992; 326: 845-851.
10. Wingard JR, Merz WG, Rinaldi MG et al. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New Engl J Med 1991; 325: 1274-1277.
11. Tricot G, Joosten E, Boogaerts MA et al. Ketoconazole vs itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Rev Infect Dis 1987; 9 (Suppl. 1): S94-S99.
12. Conneally E, Cafferkey MT, Daly PA et al. Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients. Bone Marrow Transplant 1990; 5: 403-406.
13. Perfect JR, Klotman ME, Gilbert CC et al. Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. J Infect Dis 1992; 165: 891-897.
14. Tollemar J, Ringden O, Andersson S et al. Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients. Bone Marrow Transplant 1993; 12: 577-582.